¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29
±³À°ÀÏÀÚ : 2018-07-29
±³À°Àå¼Ò : ¼­¿ï¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : KGOG 2018 Summer Workshop Uterine Cancer      
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
¿¬¶ôó : 02-512-5420  
À̸ÞÀÏ : koreagynonco@hanmail.net      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 10,000¿ø      
ºñ°í       
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 07¿ù 29ÀÏ  08:55~09:00 Orientation  ÀÌÁ¾¹Î(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 07¿ù 29ÀÏ  09:00~09:20 TCGA genomic classification of endometrial cancer  ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  09:20~09:40 Current clinical guidelines and review of background trials  À̱¤¹ü(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  09:40~10:00 Future perspective and novel treatment  ÁÖ¿ø´ö(Â÷ÀÇ°ú´ëÇÐ) 
Åä·Ð 07¿ù 29ÀÏ  10:00~10:10 Discussion  () 
±³À°½Ã°£ 07¿ù 29ÀÏ  10:30~10:50 Molecular profiles of non-endometrioid endometrial cancer  ±è¹Ì°æ(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  10:50~11:10 Current clinical guidelines and review of background trials  ¹Ú»óÀÏ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 07¿ù 29ÀÏ  11:10~11:30 Future perspective and novel treatment  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
Åä·Ð 07¿ù 29ÀÏ  11:30~11:40 Discussion  () 
±³À°½Ã°£ 07¿ù 29ÀÏ  11:40~12:00 Preoperative assessment for the risk of uterine sarcoma  À̹æÇö(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  12:00~12:20 Optimal adjuvant treatment according to sarcoma subtype  ÀÌ¿ø¹«(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  12:20~12:40 Strategy in combination of targeted therapy in advanced, recurrent uterine sarcoma  ±èÁø¿µ(°è¸íÀÇ´ë) 
Åä·Ð 07¿ù 29ÀÏ  12:40~12:50 Discussion  () 
±³À°½Ã°£ 07¿ù 29ÀÏ  13:50~14:10 Sentinel node biopsy : Current status and upcoming KGOG study  ±è´ë¿¬(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  14:10~14:40 Phase III trial to confirm the superiority of pelvic and para-aortic lymphadenectomy to pelvic lymphadenectomy alone for endometrial cancer: Japan Clinical Oncology Group Study 1412 (SEPAL-P3)  Hidemichi Watari(Hokkaido University Hospital) 
Åä·Ð 07¿ù 29ÀÏ  14:40~14:50 Discussion  () 
±³À°½Ã°£ 07¿ù 29ÀÏ  14:50~15:10 History and guidelines for management of Lynch syndrome  ±è¹Î±Ô(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  15:10~15:30 Current status in managing hereditary colorectal cancer  ±è´ö¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 07¿ù 29ÀÏ  15:30~15:50 Future perspective for hereditary endometrial cancer  ÃÖ¹Îö(Â÷ÀÇ°ú´ëÇÐ) 
Åä·Ð 07¿ù 29ÀÏ  15:50~16:00 Discussion  () 
±³À°½Ã°£ 07¿ù 29ÀÏ  16:20~17:20 Recent precision medicine in recurrent ovarian cancer -how to maximize patient treatment outcome-  ¹ÌÁ¤() 
Åä·Ð 07¿ù 29ÀÏ  17:20~17:30 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29
´ÙÀ½±Û ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 45 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 47 2024-06-18
21015 ¼­¿ï (¿Â¶óÀÎ) 2024³â Á¦1Â÷ ÇÑÀϺ´¿ø °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-27 0 74 2024-06-18
21014 °æ³² Çѱ¹¿©ÀÚÀÇ»çȸ °æ³²Áöȸ 6¿ù Çмú½ÉÆ÷Áö¾ö : 2024-06-27 0 52 2024-06-18
21013 ¿ï»ê Á¦50ȸ ´ëÇÑ¿Ü°úÇÐȸ ¿ï»êÁöȸ : 2024-06-26 0 75 2024-06-18
21012 °æ±â ÀÌõ½ÃÀÇ»çȸ ¿¬¼ö°­ÁÂ(Æó±â´É°Ë»çÀÇ Çؼ®, õ½ÄÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-26 0 66 2024-06-18
21011 ºÎ»ê 2024 »ç»ó±¸ÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ(¸¸¼º±âħ, ÀÇ·á±â°ü Àλç³ë¹«) : 2024-06-26 0 61 2024-06-18
21010 ¼­¿ï (¿Â¶óÀÎ) ¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ(Àú½ÅÀå°ú ¼ºÀåÈ£¸£¸ó Ä¡·á, ½Å»ý¾ÆÁúȯ) : 2024-06-25 0 66 2024-06-18
21009 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾư¨¿°ÇÐȸ Á¦192Â÷ ¿ù·Ê¿¬¼ö°­Á : 2024-06-25 0 76 2024-06-18
21008 ºÎ»ê ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ºÎ»ê°æ³²Áöȸ Çмúȸ : 2024-06-25 0 66 2024-06-17
21007 °æ³² â¿ø½Ã ¼Ò¾Æû¼Ò³â°úÁöȸ ¿¬¼ö°­ÁÂ(¼Ò¾Æ ¼ÒÈ­±â Áúȯ) : 2024-06-25 0 87 2024-06-17
21006 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Çмúȸ(±¸°­°ÇÁ¶Áõ) : 2024-06-25 0 51 2024-06-17
21005 ¼­¿ï (¿Â¶óÀÎ) 2024³â 6¿ù ¼Ò¾Æ½ÉÃÊÀ½ÆÄ Áý´ãȸ : 2024-06-24 0 46 2024-06-17
21004 °æ±â 2024³â ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Á¦2Â÷ Áý´ãȸ(¿Â¶óÀÎ) : 2024-06-24 0 52 2024-06-17
21003 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 21 2024-06-17
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷